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Conclusions:Our results showed the prognostic role of PD-L1, TGF-b and CD8þ TILs
in patients with advanced TETs, and their potential for development of anti-PD-1/PD-
L1 therapies.
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Background: Pulmonary LCNEC is a rare tumor. Twomutually exclusive subtypes of
LCNEC are recognized, the co-mutated TP53 and RB1 and the STK11/KEAP1 (pre-
dominantly RB1 wildtype) group.We investigated PD-L1 expression in a well charac-
terized stage IV LCNEC cohort and compared expression in the two subtypes.
Methods: Panel-consensus pathology revision was performed along with targeted next
generation sequencing (TNGS) for genes TP53, RB1, STK11 and KEAP1 and immuno-
histochemical (IHC) analysis of RB1, on pretreatment tumor samples of stage IV
LCNEC treated with chemotherapy (Derks et al. CCR 2018). IHC staining for PD-L1
(DAKO 28-8) was performed according to standard protocols on the DAKO autos-
tainer and evaluated by an experienced screener. Tumors were scored positive if> 1%
of tumor cells showed anymembranous staining. Overall survival (OS) was evaluated
by KaplanMeier analysis and differences estimated with Log-Rank test. Cox-regression
analysis included PD-L1, age and gender.
Results: PD-L1 IHC expression data could be generated in 98/147 confirmed LCNEC
samples along with RB1 IHC (n¼ 97) of which 77 passed quality control for TNGS.
PD-L1 expression was positive in 16/98 cases (16%); n¼ 5 (5%) with>50%, n¼ 11
(11%) having>1-50% and n¼ 82 (82%) with1%membranous staining, respec-
tively. No significant correlation of PD-L1 expression with molecular subtyping of
LCNECwas identified (Table). PD-L1 expression was correlated with a superior OS,
hazard ratio (HR) 0.54 ((95%Confidence interval (CI), 0.31-0.96) P¼ 0.034.
Table: 1813P Expression of PD-L1 in LCNEC, correlated to
molecular data
PD-L1 þ PD-L1 - P-value
LCNEC (n¼ 98) 16% 84% -
1-5% 7 % - -
5-20 4% - -
>50 5% - -
Rb1 IHC (n¼ 97)
RB1 (þ) (n¼ 29) 10% 90% NS
RB1 (-) (n¼ 68) 19% 81%
Mutation status (n¼ 76)
RB1/TP53 mutated (n¼ 33) 15% 85% NS
RB1 wildtype (n¼ 43) 16% 84%
OS in months (95% CI) 8.9
(4.2-13.6)
6.6
(5.7-7.6)
HR 0.54
(0.31-0.96) P¼ 0.034
Conclusions: PD-L1 expression was positive in 16% of stage IV LCNEC tumors. PD-
L1 expression is an independent process from LCNECmolecular subgroups. In
LCNEC patients with PD-L1 expression superior OS is observed compared to those
with negative PD-L1 tumors.
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Background: Spread through air spaces (STAS) is a recently-recognized invasive pat-
tern of lung cancer defined as ‘micropapillary clusters, solid nests or single cells beyond
the edge of the tumor into air spaces.’ Since STAS has been shown to be a significant
prognosticator for the postoperative survival, predicting STAS preoperatively by com-
puted tomography (CT)might help determine the optimum surgical procedures.
Methods: Information on STAS and preoperative CT were availablen 327 patients with
resected lung adenocarcinomas. STAS was defined as tumor cells within air spaces in
the lung parenchyma beyond the edge of the main tumor. The association of STAS with
CT characteristics, such as vascular convergence, ground glass opacity (GGO), air
bronchogram, notch, pleural indentation, spiculation, and cavitation, was analyzed.
Results: Among the 327 patients with resected adenocarcinoma, 191 (58.4%) were pos-
itive for STAS. A univariable analysis demonstrated that STAS-positive adenocarcino-
mas were significantly associated with a larger radiological tumor diameter (P¼ 0.02),
the presence of vascular convergence (P< 0.01), notch (P< 0.01), pleural indentation
(P¼ 0.03), spiculation (P< 0.01), and the absence of GGO (P< 0.01) compared with
STAS-negative ones. In amultivariable analysis, the presence of notch (P¼ 0.01) and
the absence of GGO (P< 0.01) were shown to be significantly associated with the STAS
phenomenon. The odds ratio for STAS of notch-positive and GGO-negative adenocar-
cinomas against notch-negative and GGO-positive ones was 5.01 (P< 0.01).
Conclusions: The presence of notch and the absence of GGOwere independently asso-
ciated with the STAS phenomenon. These results will prove helpful in identifying
STAS-positive adenocarcinoma by CT prior to surgical resection.
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Background: To explore the different expression of proteins and the acetylations
between esophageal squamous carcinoma cells (ESCCs) and cancer stem-like cells
(CSCs) by proteomic analysis.
Methods: The Eca109 cells were divided into CSCs group and ESCCs group by using
serum-free culture and serum culture. Wemeasured the CD44 expression levels, CCK8
cell proliferations and plate cloning formation to identify the characteristics of cancer
stem cells. Furthermore, TandemMass Tags (TMT)-based quantitative proteomics
and bioinformatic analysis were used to detect proteomics and bioinformatic analysis.
Results: The positive rate of CD44 and CCK8 cell proliferation experience in the CSCs
group were higher than ESCCs group (P< 0.05). The plate cloning formation showed
that the values of D0, Dq, N and SF2 were significantly higher in the CSCs group, and
the radiation sensitization ratio was 1.556. Furthermore, 5,262 proteins were identified
in the two groups in total. The up-regulation of 187 proteins and down-regulation of
83 proteins were detected in CSCs group (>1.5 times). Bioinformatic analysis further
revealed that those quantifiable proteins were mainly involved in multiple biological
functions and metabolic processes, including steroid biosynthesis, protein processing
in endoplasmic reticulum, metabolic pathways and oxidative phosphorylation path-
ways. In addition, 53 acetylated sites were increased and 67 acetylated sites were
decreased in CSCs group (>1.5 times). Those acetylated sites were involved in the regu-
lation of DNAmetabolic process, the function of cell adhesion, glycolysis and gluco-
neogenic pathway.
Conclusions:We provides a global survey of proteins and acetylations in ESCCs and
CSCs. These proteins and acetylations may be related to the radiosensitivity, recurrence
andmetastatic of esophageal squamous carcinoma and could be a potential new target
for esophageal squamous carcinoma.
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